EUVIMEDEUVIMED entdecken
Editorial

The Pitfalls of Disproportionality Analysis: Insights on Their Interwoven Complexity and a Front-End Mitigation Strategy

Manfred Hauben, Rave Harpaz, Robert Weber

Drug Safety · 2026-12 · 49 (12) · 1541-1546

DOI: 10.1007/s40264-026-01707-0 ↗

Kurz gefasst

Editorial in der Zeitschrift Drug Safety, online erschienen am 17.09.2026. Verfasst von Manfred Hauben und 2 weiteren Autor:innen. Beteiligte Einrichtung: Merck Healthcare KGaA, Frankfurter Straße 250, 64293, Darmstadt, Germany. manfred.hauben@emdserono.com. Die Arbeit nennt 12 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Autor:innen und Institutionen

  • Merck Healthcare KGaA, Frankfurter Straße 250, 64293, Darmstadt, Germany. manfred.hauben@emdserono.com.
  • Department of Family and Community Medicine, New York Medical College, 40 Sunshine Cottage Rd, Valhalla, NY, 10595, USA. manfred.hauben@emdserono.com.
  • Oracle, 100 Oracle Pkwy, Redwood City, CA, 94065, USA.

Zitieren

APA

Hauben, M., Harpaz, R., & Weber, R. (2026). The Pitfalls of Disproportionality Analysis: Insights on Their Interwoven Complexity and a Front-End Mitigation Strategy. Drug Safety, 49(12), 1541-1546. https://doi.org/10.1007/s40264-026-01707-0

Vancouver

Hauben M, Harpaz R, Weber R. The Pitfalls of Disproportionality Analysis: Insights on Their Interwoven Complexity and a Front-End Mitigation Strategy. Drug Safety. 2026;49(12):1541-1546. doi:10.1007/s40264-026-01707-0

BibTeX
@article{Hauben2026,
  author = {Hauben, Manfred and Harpaz, Rave and Weber, Robert},
  title = {The Pitfalls of Disproportionality Analysis: Insights on Their Interwoven Complexity and a Front-End Mitigation Strategy},
  journal = {Drug Safety},
  year = {2026},
  volume = {49},
  number = {12},
  pages = {1541--1546},
  doi = {10.1007/s40264-026-01707-0}
}
Kostenlos starten →